| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman And Chief Scientist | Chief Scientist | Director, 10% Owner +1 more
1 company
Javitt Jonathan C serves as a Chairman And Chief Scientist at NRXP. Across recent SEC filings that breaks down to 4 buys and 1 sell. Those positions are worth an estimated $99K at current prices.
Historically, Javitt Jonathan C's trades have earned a middling insider score of 62/100 across 5 rated trades. Over a 12-month horizon, 60.0% of those trades were profitable, with an average 12-month return of +15.7%.
The biggest single holding is NRXP (~$99K) as Chairman And Chief Scientist. Net of sales, the recent Form 4 record there shows accumulation of 40,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17, 2024 | NRXP Nrx Pharmaceuticals, Inc. | Chairman And Chief Scientist | Buy | 40,000 | $1.17 | $46,800.00 | +89.6% | +25.0% | +39.0% | |
| Aug 23, 2023 | NRXP Nrx Pharmaceuticals, Inc. | Chief Scientist | Buy | 100,000 | $0.33 | $33,000.00 | +28.9% | +3.7% | -28.0% | |
| Aug 22, 2023 | NRXP Nrx Pharmaceuticals, Inc. | Chief Scientist | Buy | 200,000 | $0.32 | $64,400.00 | +136.7% | +3.2% | -37.0% | |
| Dec 7, 2022 | NRXP Nrx Pharmaceuticals, Inc. | Director, 10% Owner | Sell | 400,000 | $1.00 | $400,000.00 | -3.0% | -50.0% | -77.1% | |
| Jun 1, 2022 | NRXP Nrx Pharmaceuticals, Inc. | Chief Scientist | Buy | 100,000 | $58.00 | $5,800,000.00 | +215.8% | +13.7% | +27.6% |